Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.
Leukemia
; 35(9): 2736-2737, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34341480
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
China